Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Debt Ratio (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Debt Ratio for 9 consecutive years, with 0.09 as the latest value for Q4 2023.

  • Quarterly Debt Ratio fell 41.39% to 0.09 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 0.09 through Dec 2023, down 41.39% year-over-year, with the annual reading at 0.09 for FY2023, 41.39% down from the prior year.
  • Debt Ratio for Q4 2023 was 0.09 at Cartesian Therapeutics, down from 0.17 in the prior quarter.
  • The five-year high for Debt Ratio was 0.53 in Q3 2019, with the low at 0.09 in Q4 2023.
  • Average Debt Ratio over 5 years is 0.2, with a median of 0.16 recorded in 2021.
  • The sharpest move saw Debt Ratio skyrocketed 58.9% in 2019, then crashed 74.33% in 2020.
  • Over 5 years, Debt Ratio stood at 0.19 in 2019, then decreased by 21.07% to 0.15 in 2020, then increased by 6.98% to 0.16 in 2021, then decreased by 1.26% to 0.16 in 2022, then crashed by 41.39% to 0.09 in 2023.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.09, 0.17, and 0.17 for Q4 2023, Q2 2023, and Q1 2023 respectively.